国大药房品牌怎么样 申请店铺

我要投票 国大药房在连锁药店行业中的票数:3 更新时间:2024-11-21
国大药房是哪个国家的品牌?「国大药房」是 中国医药集团有限公司 旗下著名品牌。该品牌发源于北京,由创始人佘鲁林在1987-03-26期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
国大药房怎么样


国药控股国大药房有限公司(简称"国大药房")创立于2004年,注册资金6亿元人民币。隶属于中国医药集团旗下的著名企业----国药控股股份有限公司(01099.HK)。国大药房是一家全国性的大型医药零售连锁企业,总部设在上海。

截至2011年底,国大药房经过并购和资产重组,已在北京、上海、天津、辽宁、江苏、安徽、浙江、山东、福建、广东、广西、宁夏、新疆、山西、湖南、河南、内蒙古等省、市、自治区建立了二十多家区域性连锁公司,覆盖全国40多个大中城市,拥有1753家零售药店,形成了星如棋布的国大药房网络,实现了销售和规模的快速增长,2011年公司销售总额37.2亿,在我国药品零售行业名列前茅。

公司是我国医药零售连锁行业排名前十名企业中唯一的国有控股企业,其医保定点药房的占比高于其他连锁企业。在我国医药体制改革进程中,公司在中国医药集团国总公司做强做优中央企业医药健康产业发展平台的大背景下,借助于国药控股强大的资本、品牌、分销和物流网络的优势,依托国大药房的全国ERP平台、精细化管理等优势,全面打造具有"成本领先,品种齐全,服务优良,价值提升"的全国医药零售终端网络,万民员工以昂扬向上的姿态,在我国医药体制改革中,谱写出为民健康事业发展的新篇章。

国大药房的业态模式有:专业药房深入社区,为居民提供专业的健康产品和专业的药学服务,是居民身边的"健康好邻居";平价药房药品齐全,品种丰富,价格实惠,是百姓身边的"民生服务站"。作为全国性的药品零售主导品牌,国大药房以关爱顾客健康为己任,以齐全的药品选择和专业的药学为服务优势,让广大消费者获得专业、周全、温馨的健康服务。"健康所需,全在国大"!

公司打造全国性零售药店的知名品牌,公司旗下拥有"国大药房"、"一致药店"、"大德生"、"天益堂"、"光华大药房"、"乐仁堂"等品牌,其中"乐仁堂"、"大德生"、"天益堂"、"光华"被国家商业部认定为"中华老字号",是我国行业内拥有知名品牌最多的全国性连锁企业。自2012年开始,公司逐步归一为"国大药房",实现品牌价值的最大化,品牌美誉度的集中体现。

秉承中国医药集团总公司"关爱生命,呵护健康"的企业理念,公司以"健康发展,创新经营,打造核心竞争力"为主题,以"提供家庭健康产品和服务"为使命,尽其全力实现"中国健康产品零售业的领航者"的愿景。


Guoda pharmacy Co., Ltd. (hereinafter referred to as "Guoda pharmacy") was founded in 2004 with a registered capital of 600 million yuan. It is a famous enterprise under China Pharmaceutical Group, Sinopharm Holding Co., Ltd. (01099. HK). Guoda pharmacy is a national large-scale pharmaceutical retail chain enterprise, headquartered in Shanghai. By the end of 2011, through M & A and asset restructuring, Guoda pharmacy has established more than 20 regional chain companies in Beijing, Shanghai, Tianjin, Liaoning, Jiangsu, Anhui, Zhejiang, Shandong, Fujian, Guangdong, Guangxi, Ningxia, Xinjiang, Shanxi, Hunan, Henan, Inner Mongolia and other provinces, cities and autonomous regions, covering more than 40 large and medium-sized cities in China, with 1753 retail pharmacies In 2011, the company's total sales reached 3.72 billion, ranking among the top in China's pharmaceutical retail industry. The company is the only state-owned holding enterprise among the top ten pharmaceutical retail chain enterprises in China, and its proportion of designated pharmacies for medical insurance is higher than that of other chain enterprises. In the process of China's pharmaceutical system reform, under the background of strengthening and optimizing the development platform of central enterprise's pharmaceutical health industry of China National Pharmaceutical Corporation, relying on the advantages of Sinopharm's powerful capital, brand, distribution and logistics network, relying on the advantages of the whole country's ERP platform and refined management of Sinopharm, the company has comprehensively built a "leading cost, complete varieties and services The national pharmaceutical retail terminal network with excellent service and improved value has created a new chapter for the development of people's health in the reform of China's pharmaceutical system. The business models of Guoda pharmacy include: professional pharmacy goes deep into the community, provides professional health products and professional pharmaceutical services for residents, and is a "good health neighbor" around residents; affordable pharmacy is a "service station for people's livelihood" around people with complete drugs, rich varieties and affordable prices. As a national leading brand of drug retail, Guoda pharmacy takes care of the health of customers as its own duty, with complete drug selection and professional pharmacy as its service advantages, so that consumers can get professional, comprehensive and warm health services. "Health needs, all at the National University"! The company has built a famous brand of national retail drugstores. It owns such brands as "Guoda Drugstore", "Tongyi Drugstore", "DaDeSheng", "Tianyitang", "Guanghua Drugstore" and "lerentang", among which "lerentang", "DaDeSheng", "Tianyitang" and "Guanghua" are recognized as "Chinese time-honored brands" by the Ministry of Commerce, and it is the national chain enterprise with the most famous brands in the industry of China. Since 2012, the company has gradually merged into "Guoda pharmacy" to maximize the brand value and reflect the brand reputation. Adhering to the corporate philosophy of "caring for life and health" of China Pharmaceutical Group Corporation, with the theme of "healthy development, innovative operation, and building core competitiveness", with the mission of "providing family health products and services", the company makes every effort to realize the vision of "leader of China's health product retail industry".

本文链接: https://brand.waitui.com/caf6a3801.html 联系电话:010*****727 立即查看

千城特选小程序码

7×24h 快讯

拼多多:第三季度营收增速环比下降,将坚定高质量发展战略应对竞争挑战

36氪获悉,拼多多发布2024年第三季度财报。财报显示,本季度拼多多营收达到994亿元,与上个季度相比,营收的增速有所放缓。业内分析认为,一方面是因为电商行业的竞争依然激烈,另一方面是平台的“百亿减免”等举措影响了短期的财报表现。“为了应对行业竞争,我们将坚定地执行高质量发展战略,继续实行‘减免+扶持’的举措,持续完善平台及产业生态,为供需两侧带来更大的普惠。”拼多多陈磊表示。

2小时前

拼多多:第三季度利润环比下降22%,将长期投入“新质供给”“电商西进”战略

36氪获悉,拼多多发布2024年第三季度财报。财报显示,本季度拼多多利润达到250亿元,环比下降22%。过去这个季度,拼多多先后推出“百亿减免”“电商西进”“新质商家扶持计划”等重磅举措,持续扩大对生态建设的投资,一定程度上影响了短期的财报表现。拼多多陈磊表示,在财务数据之外,我们更加看重生态投资带来的长期价值,未来几个季度,拼多多将继续投入“新质供给”“电商西进”等战略,给用户、商家及产业带来更长远的回报。

2小时前

莎普爱思:股东拟合计减持不超5%公司股份

36氪获悉,莎普爱思公告,股东陈德康持有公司12.39%股份,上海景兴实业投资有限公司持有公司4.7%股份。陈德康计划减持公司股份数量合计不超过758.32万股,即不超过公司总股本的2%。上海景兴计划减持公司股份数量合计不超过1137.48万股,即不超过公司总股本的3%。

2小时前

永杰新材上交所主板IPO申请获证监会同意注册批复

36氪获悉,证监会下发关于同意永杰新材料股份有限公司首次公开发行股票注册的批复,同意该公司首次公开发行股票的注册申请。根据招股书,该公司拟在上交所主板上市,公司专业从事铝板带箔的研发、生产与销售,产品主要包括铝板带和铝箔两大类。

2小时前

东方电缆:公司及子公司近期中标合计约40亿元海底电缆项目

36氪获悉,东方电缆公告,公司及全资子公司东方海工院近期收到相关通知书,确认公司及东方海工院联合体为相关项目中标人。其中,直流海底电缆项目中标金额约15.14亿元,交流海底电缆项目中标金额合计约24.72亿元,以上项目合计中标金额约40亿元。同日公告,公司拟以自有资金投资建设东方中央研究院·总部项目,项目总投资金额约为5.54亿元。

2小时前

本页详细列出关于益丰大药房的品牌信息,含品牌所属公司介绍,益丰大药房所处行业的品牌地位及优势。
咨询